Skip to main content
Signal8

AH Equity Partners Bio I, L.L.C.

SEC insider (Form 3/4/5 filer). CIK 0001656626. 10% Owner at Camp4 Therapeutics Corp (CAMP). 3 reported Form 4/5 transactions since Sep 2024; latest on Oct 15, 2024. Located in MENLO PARK, CA.

Companies AH Equity Partners Bio I, L.L.C. has filed insider reports for

  • Camp4 Therapeutics Corp (CAMP): 10% Owner
AH Equity Partners Bio I, L.L.C. profile photo

AH Equity Partners Bio I, L.L.C.

CIK: 0001656626

Transaction Breakdown

Open Market Buys (P)2 (66.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Camp4 Therapeutics Corp logo
CAMP

Camp4 Therapeutics Corp

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Oct 15, 2024
    Conversion
    Indirect
    1.4M shares-
  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Oct 15, 2024
    Purchase
    Indirect
    181.8K shares at avg. $11.00$2.0M
  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Oct 15, 2024
    Purchase
    Indirect
    545.5K shares at avg. $11.00$6.0M

1-3 of 3